Ascendis Pharma AS (NAS:ASND)
$ 124.33 -2.22 (-1.75%) Market Cap: 7.43 Bil Enterprise Value: 7.88 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 74/100

Ascendis Pharma A/S Corporate Call Transcript

Apr 03, 2023 / 12:30PM GMT
Release Date Price: $72.83 (-32.07%)
Operator

Good day, and welcome to the Ascendis Pharma update call. (Operator Instructions) As a reminder, this call may be recorded. I would now like to turn the call over to Tim Lee, Senior Director, Investor Relations at Ascendis Pharma. You may begin.

Timothy J. Lee;S;Senior Director of IR
Ascendis Pharma A

/-

Thank you, operator, and thank you, everyone, for joining our conference call this morning. I am Tim Lee, Senior Director, Investor Relations. Joining me on the call today is Jan Mikkelsen, President and Chief Executive Officer.

Before we begin, I would like to remind you that this conference call will contain forward-looking statements that are intended to be covered under the safe harbor provided by the Private Securities Litigation Reform Act.

Words such as believes, anticipates, plans, expects, indicates, will, intends, potential, suggest, assuming, designed and similar expressions are intended to identify forward-looking statements. Examples of such statements may include, but are not limited to,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot